OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kinetics of viral load and antibody response in relation to COVID-19 severity
Yanqun Wang, Lu Zhang, Ling Sang, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5235-5244
Open Access | Times Cited: 573

Showing 1-25 of 573 citing articles:

Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1749

Risk factors for severe and critically ill COVID‐19 patients: A review
Yadong Gao, Mei Ding, Xiang Dong, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 428-455
Open Access | Times Cited: 1282

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
Anthony T. Tan, Martin Linster, Chee Wah Tan, et al.
Cell Reports (2021) Vol. 34, Iss. 6, pp. 108728-108728
Open Access | Times Cited: 692

Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
Edith L. Graham, Jeffrey R. Clark, Zachary S. Orban, et al.
Annals of Clinical and Translational Neurology (2021) Vol. 8, Iss. 5, pp. 1073-1085
Open Access | Times Cited: 596

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
Katharina Röltgen, Abigail E. Powell, Oliver F. Wirz, et al.
Science Immunology (2020) Vol. 5, Iss. 54
Open Access | Times Cited: 469

Neutralizing antibody titres in SARS-CoV-2 infections
Eric H. Y. Lau, Owen TY Tsang, David S.C. Hui, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 358

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
Nina Le Bert, Hannah Clapham, Anthony T. Tan, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 5
Open Access | Times Cited: 321

A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
Vincent Legros, Solène Denolly, Manon Vogrig, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 2, pp. 318-327
Open Access | Times Cited: 320

Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years
Chadi M. Saad-Roy, Caroline E. Wagner, Rachel E. Baker, et al.
Science (2020) Vol. 370, Iss. 6518, pp. 811-818
Open Access | Times Cited: 300

Global absence and targeting of protective immune states in severe COVID-19
Alexis J. Combes, Tristan Courau, Nicholas F. Kuhn, et al.
Nature (2021) Vol. 591, Iss. 7848, pp. 124-130
Open Access | Times Cited: 247

Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Yannick Galipeau, Matthew Greig, George Liu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 242

Correlates of protection against SARSCoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233

Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier
Lael M. Yonker, Tal Gilboa, Alana F. Ogata, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 14
Open Access | Times Cited: 221

Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Kai Wang, Quanxin Long, Haijun Deng, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 3, pp. e531-e539
Open Access | Times Cited: 212

Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities
Matteo Chiara, Anna Maria D’Erchia, Carmela Gissi, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 616-630
Open Access | Times Cited: 200

RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Zezhong Liu, Wei Xu, Shuai Xia, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 190

Suboptimal SARS-CoV-2−specific CD8 + T cell response associated with the prominent HLA-A*02:01 phenotype
Jennifer R. Habel, Thi H. O. Nguyen, Carolien E. van de Sandt, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 39, pp. 24384-24391
Open Access | Times Cited: 186

Mapping and role of T cell response in SARS-CoV-2–infected mice
Zhen Zhuang, Xiaomin Lai, Jing Sun, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 4
Open Access | Times Cited: 168

COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
Alison E. John, Chitra Joseph, Gisli Jenkins, et al.
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 228-240
Open Access | Times Cited: 165

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
David M. Smadja, Steven J. Mentzer, Michaëla Fontenay, et al.
Angiogenesis (2021) Vol. 24, Iss. 4, pp. 755-788
Open Access | Times Cited: 164

Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
Lok-Yin Roy Wong, Stanley Perlman
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 47-56
Open Access | Times Cited: 162

Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals
Fang Gong, Yaping Dai, Ting Zheng, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 12, pp. 6588-6599
Open Access | Times Cited: 156

Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19
Samuele Notarbartolo, Valeria Ranzani, Alessandra Bandera, et al.
Science Immunology (2021) Vol. 6, Iss. 62
Open Access | Times Cited: 155

SARS-CoV-2-specific T cells in infection and vaccination
Antonio Bertoletti, Nina Le Bert, Martin Qui, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2307-2312
Open Access | Times Cited: 150

Immunity to SARS‐CoV‐2 induced by infection or vaccination
Xaquín Castro Dopico, Sebastian Ols, Karin Loré, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 1, pp. 32-50
Open Access | Times Cited: 145

Page 1 - Next Page

Scroll to top